DJ Nutt and AL Malizia

Why does the world have such a `down' on antidepressants?
J Psychopharmacol 2008 22: 223-226. [PDF] [References]  

JC Verster and DJ Cox

ADHD, methylphenidate and driving: does some legislation endanger public health?
J Psychopharmacol 2008 22: 227-229. [PDF] [References]  

Joris C Verster, Evelijne M Bekker, Marlise de Roos, Anita Minova, Erik JE Eijken, JJ Sandra Kooij, Jan K. Buitelaar, J Leon Kenemans, Marinus N. Verbaten, Berend Olivier, and Edmund R Volkerts

Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial
J Psychopharmacol 2008 22: 230-237. [Abstract] [PDF] [References]  

L. Waddell and M. Taylor

A new self-rating scale for detecting atypical or second-generation antipsychotic side effects
J Psychopharmacol 2008 22: 238-243. [Abstract] [PDF] [References]  

Amna Mir, Kuppuswami Shivakumar, Richard J Williamson, Victoria McAllister, Veronica O'Keane, and Katherine J Aitchison

Change in sexual dysfunction with aripiprazole: a switching or add-on study
J Psychopharmacol 2008 22: 244-253. [Abstract] [PDF] [References]  

VA Curtis, K. Katsafouros, H-J. Möller, R. Medori, and E. Sacchetti

Long-acting risperidone improves negative symptoms in stable psychotic patients
J Psychopharmacol 2008 22: 254-261. [Abstract] [PDF] [References]  

Stéphane Potvin, Édouard Kouassi, Olivier Lipp, Roch-Hugo Bouchard, Marc-André Roy, Marie-France Demers, Alain Gendron, Giuseppe Astarita, Daniele Piomelli, and Emmanuel Stip

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
J Psychopharmacol 2008 22: 262-269. [Abstract] [PDF] [References]  

AlA Fingelkurts, S. Kähkönen, AnA Fingelkurts, R. Kivisaari, S. Borisov, V. Puuskari, O. Jokela, and T. Autti

Reorganization of the composition of brain oscillations and their temporal characteristics during opioid withdrawal
J Psychopharmacol 2008 22: 270-284. [Abstract] [PDF] [References]  

DAF Robertson, JE Beattie, IC Reid, and DJK Balfour

Influence of 5,7-dihydroxytryptamine lesions of the rat fornix—fimbria and cingulum bundles on spontaneous activity in an aversive maze
J Psychopharmacol 2008 22: 285-289. [Abstract] [PDF] [References]  

SK Grimond-Billa, C Norman, GW Bennett, and HJ Cassaday

Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect
J Psychopharmacol 2008 22: 290-299. [Abstract] [PDF] [References]  

C. Norman, Srg Beckett, CH Spicer, D. Ashton, X. Langlois, and GW Bennett

Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion
J Psychopharmacol 2008 22: 300-307. [Abstract] [PDF] [References]  

PJ Harrison, L. Lyon, LJ Sartorius, Pwj Burnet, and TA Lane

Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
J Psychopharmacol 2008 22: 308-322. [Abstract] [PDF] [References]  

RI Ohlsen, R. Williamson, B. Yusufi, J. Mullan, D. Irving, S. Mukherjee, E. Page, KJ Aitchison, and TRE Barnes

Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine
J Psychopharmacol 2008 22: 323-329. [Abstract] [PDF] [References]  

Aung Tint, Peter M Haddad, and Ian M Anderson

The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
J Psychopharmacol 2008 22: 330-332. [Abstract] [PDF] [References]  

Demet Ozen Yalcin, Erol Goka, M Cigdem Aydemir, and Cebrail Kisa

Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report
J Psychopharmacol 2008 22: 333-335. [Abstract] [PDF] [References]  

Abrar Hussain and John Burke

Mirtazapine associated with recurrent pancreatitis — a case report
J Psychopharmacol 2008 22: 336-337. [Abstract] [PDF] [References]  

David Nutt

Reply to OCD letter
J Psychopharmacol 2008 22: 338. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.